226 related articles for article (PubMed ID: 27379850)
21. Langerhans cell histiocytosis: A neoplastic disorder driven by Ras-ERK pathway mutations.
Tran G; Huynh TN; Paller AS
J Am Acad Dermatol; 2018 Mar; 78(3):579-590.e4. PubMed ID: 29107340
[TBL] [Abstract][Full Text] [Related]
22. Congenital aggressive variant of Langerhans cells histiocytosis with CD56+/E-Cadherin- phenotype.
Lucioni M; Beluffi G; Bandiera L; Zecca M; Inzani F; Fiandrino G; Viglio A; Stronati M; Necchi V; Riboni R; Locatelli F; Paulli M
Pediatr Blood Cancer; 2009 Dec; 53(6):1107-10. PubMed ID: 19621455
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous adult xanthogranuloma with a small portion of BRAF
Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
[TBL] [Abstract][Full Text] [Related]
24. Langerhans cell histiocytosis first presenting in the skin in adults: frequent association with a second haematological malignancy.
Edelbroek JR; Vermeer MH; Jansen PM; Stoof TJ; van der Linden MM; Horváth B; van Baarlen J; Willemze R
Br J Dermatol; 2012 Dec; 167(6):1287-94. PubMed ID: 22835048
[TBL] [Abstract][Full Text] [Related]
25. Digestive tract involvement with exudative enteropathy in Langerhans cell histiocytosis.
Boccon-Gibod LA; Krichen HA; Carlier-Mercier LM; Salaun JF; Fontaine JL; Leverger GR
Pediatr Pathol; 1992; 12(4):515-24. PubMed ID: 1409150
[TBL] [Abstract][Full Text] [Related]
26. CyclinD1 Is Useful to Differentiate Langerhans Cell Histiocytosis From Reactive Langerhans Cells.
Chatterjee D; Vishwajeet V; Saikia UN; Radotra B; De D; Bansal D
Am J Dermatopathol; 2019 Mar; 41(3):188-192. PubMed ID: 30124506
[TBL] [Abstract][Full Text] [Related]
27. Langerhans cell histiocytosis of the skin.
Munn S; Chu AC
Hematol Oncol Clin North Am; 1998 Apr; 12(2):269-86. PubMed ID: 9561900
[TBL] [Abstract][Full Text] [Related]
28. Langerhans cell histiocytosis of the female genital tract.
Axiotis CA; Merino MJ; Duray PH
Cancer; 1991 Mar; 67(6):1650-60. PubMed ID: 2001554
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous Langerhans Cell Histiocytosis Responsive to Topical Nitrogen Mustard.
Bui AN; Puleo AE; Canales AL; Jacobsen ED; LeBoeuf NR
J Drugs Dermatol; 2020 Aug; 19(8):803-805. PubMed ID: 32845598
[TBL] [Abstract][Full Text] [Related]
30. BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases.
Alayed K; Medeiros LJ; Patel KP; Zuo Z; Li S; Verma S; Galbincea J; Cason RC; Luthra R; Yin CC
Hum Pathol; 2016 Jun; 52():61-7. PubMed ID: 26980021
[TBL] [Abstract][Full Text] [Related]
31. Localized Acral Sclerosing Langerhans Cell Histiocytosis: A New Form of Presentation of Cutaneous Langerhans Cell Histiocytosis.
Garrido MC; Salido-Vallejo R; Revilla E; Salvatierra J; Rodriguez-Peralto JL
Am J Dermatopathol; 2020 May; 42(5):356-359. PubMed ID: 31725482
[TBL] [Abstract][Full Text] [Related]
32. Langerhans cell histiocytosis mimicking molluscum contagiosum: A case series.
Fernández Armenteros JM; Arco Huguet N; Sanmartin Novell V; Vilardell Villellas F; Velasco Sanchez A; Martró Català E; Martí Laborda RM; Soria Gili X
Pediatr Blood Cancer; 2018 Jul; 65(7):e27047. PubMed ID: 29528195
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis of Langerhans cell histiocytosis.
Badalian-Very G; Vergilio JA; Fleming M; Rollins BJ
Annu Rev Pathol; 2013 Jan; 8():1-20. PubMed ID: 22906202
[TBL] [Abstract][Full Text] [Related]
34. Langerhans Cell Histiocytosis Associated With Underlying Hematolymphoid Disorders in Adults: Report of 2 Cases and Review of the Literature.
Kiavash K; Malone JC
Am J Dermatopathol; 2018 Aug; 40(8):588-593. PubMed ID: 30035752
[TBL] [Abstract][Full Text] [Related]
35. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
Johnson WT; Patel P; Hernandez A; Grandinetti LM; Huen AC; Marks S; Ho J; Monaco SE; Jaffe R; Picarsic J
J Cutan Pathol; 2016 Mar; 43(3):270-5. PubMed ID: 26454140
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the understanding of Langerhans cell histiocytosis.
Badalian-Very G; Vergilio JA; Degar BA; Rodriguez-Galindo C; Rollins BJ
Br J Haematol; 2012 Jan; 156(2):163-72. PubMed ID: 22017623
[TBL] [Abstract][Full Text] [Related]
37. Neonatal and early infantile cutaneous langerhans cell histiocytosis: comparison of self-regressive and non-self-regressive forms.
Battistella M; Fraitag S; Teillac DH; Brousse N; de Prost Y; Bodemer C
Arch Dermatol; 2010 Feb; 146(2):149-56. PubMed ID: 20157025
[TBL] [Abstract][Full Text] [Related]
38. Congenital Unilesional Cutaneous Langerhans Cell Histiocytosis: A Case Report.
Ungari M; Caresana G; Tanzi G; Drera B; Frittoli MC; Gusolfino MD; Ferrero G; Varotti E; Manotti L; Trombatore M; Bertoni R
Am J Dermatopathol; 2021 Mar; 43(3):e38-e42. PubMed ID: 32769549
[TBL] [Abstract][Full Text] [Related]
39. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?
Berres ML; Merad M; Allen CE
Br J Haematol; 2015 Apr; 169(1):3-13. PubMed ID: 25430560
[TBL] [Abstract][Full Text] [Related]
40. An infant with self-healing cutaneous Langerhans cell histiocytosis followed by isolated thymic relapse.
Hatakeyama N; Hori T; Yamamoto M; Sogawa I; Inazawa N; Tsutsumi H; Suzuki N
Pediatr Blood Cancer; 2009 Aug; 53(2):229-31. PubMed ID: 19343774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
